Neoadjuvant therapy of endometrial cancer with the aromatase inhibitor letrozole: endocrine and clinical effects

Author： Berstein L.   Maximov S.   Gershfeld E.   Meshkova I.   Gamajunova V.   Tsyrlina E.   Larionov A.   Kovalevskij A.   Vasilyev D.  

Publisher： Elsevier

ISSN： 0301-2115

Source： European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol.105, Iss.2, 2002-11, pp. : 161-165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women

By Fisher S.A.   Reid R.L.   Van Vugt D.A.   Casper R.F.  

Fertility and Sterility, Vol. 78, Iss. 2, 2002-08 ,pp. : 280-285

Elsevier

Access to resources Recommend Favorite

Menopausal-type symptoms among breast cancer patients on aromatase inhibitor therapy

By Gallicchio L.  

Climacteric, Vol. 15, Iss. 4, 2012-08 ,pp. : 339-349

Informa Healthcare

Access to resources Recommend Favorite

Effects of aromatase inhibitor on menopausal hyperplasia in a case of obesity

By Koloszar S.   Pal Z.   Kereszturi A.   Vajda G.   Pal A.   Daru J.  

Climacteric, Vol. 15, Iss. 1, 2012-02 ,pp. : 93-94

Informa Healthcare

Access to resources Recommend Favorite

Uterine metastasis of lobular breast cancer during adjuvant letrozole therapy

By Komeda S.  

Journal of Obstetrics & Gynaecology, Vol. 33, Iss. 1, 2013-01 ,pp. : 99-101

Informa Healthcare

Access to resources Recommend Favorite

Endometrial effects of letrozole and clomiphene citrate in women with polycystic ovary syndrome using spiral artery Doppler

By Baruah Jinee  

Archives of Gynecology and Obstetrics, Vol. 279, Iss. 3, 2009-03 ,pp. : 311-314

Springer Publishing Company

Access to resources Recommend Favorite